On May 13, 2026, ICU reported earnings of -0.90 USD per share (EPS) for Q1 26, missing the estimate of -0.83 USD, resulting in a -8.00% surprise. Revenue reached 495.00 thousand, compared to an expected 441.88 thousand, with a 12.02% difference. The market reacted with a -8.70% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 2 analysts forecast an EPS of -0.93 USD, with revenue projected to reach 491.37 thousand USD, implying an increase of 3.33% EPS, and decrease of -0.73% in Revenue from the last quarter.